Get in Touch

We are passionate about partnership.
Discover how we solve access, reimbursement and other complex issues in our case studies

Services

We mapped and evaluated influential thought leaders to amplify scientific narrative messaging for a gene therapy

  • Value Communication

We supported a mid-size pharma ​to assess their internal capabilities and improve organizational efficiency

  • Value Communication

Identifying alternative business models to inspire innovative pricing and reimbursement approaches across market archetypes

  • Access Strategy, Price Optimisation

We leveraged spend analysis and PULSE social listening which challenged initial hypotheses on patient perceptions

  • Price Optimisation, Digital Solutions

We created a stakeholder engagement roadmap to support the launch of a neuro-rare disease pipeline for a new entrant to the rare disease space

  • Access Strategy, Value Communication, Launch Excellence

RarePulse® social listening uncovered stakeholder perceived burdens in polycythaemia vera, laying the groundwork for future publications

  • Value Communication, Digital Solutions

Supporting a patient advocacy group by providing foundational education on the JCA and highlighting opportunities for their involvement

  • Value Communication

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy, Launch Excellence

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Access Strategy, Price Optimisation, Launch Excellence

P4A partnered with Company A to assist in developing the launch strategy for Product A in South Korea

  • Access Strategy, Launch Excellence

P4A developed a bespoke Launch Guidebook to ensure the successful launch of a new asset

  • Digital Solutions, Launch Excellence

To determine strategies for maximising price, reimbursement and market access (PRMA) potential, considering the competitive landscape and different data scenarios

  • Access Strategy, Price Optimisation

Understand payer requirements and the role of key evidence types in estimating gene therapy durability in payer assessments

  • Access Strategy

Supporting launch event for GT (large pharma)

  • Value Communication

To understand the key regulatory and competitive landscape changes that could impact a South Korean drug launch.

  • Access Strategy

Develop a patient engagement plan to support the launch of Product X and optimize PRMA outcomes via the incorporation of the patient voice

  • Value Communication

Support the UK patient organization in their engagement with NICE for the assessment of a new oncology product

  • Access Strategy, Value Communication

We supported a top 10 pharma in creating meaningful and actionable Competitor Intelligence insights in the gene therapy space​

  • Digital Solutions

We supported a mid-size company to assess the opportunity for a gene therapy platform they were planning on in-licensing​

  • Access Strategy, Price Optimisation

We helped an early stage biotech with their search strategy for a co-development partner for their CAR-T platform​

  • Access Strategy